nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Pulmonary fibrosis—Methotrexate—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Nafarelin—Loss of libido—Methotrexate—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Nafarelin—Interstitial pneumonia—Methotrexate—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Nafarelin—Hirsutism—Prednisone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Nafarelin—Acne—Prednisolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Nafarelin—Acne—Triamcinolone—ankylosing spondylitis	0.0094	0.0094	CcSEcCtD
Nafarelin—Acne—Methylprednisolone—ankylosing spondylitis	0.00938	0.00938	CcSEcCtD
Nafarelin—Herpes simplex—Prednisolone—ankylosing spondylitis	0.00933	0.00933	CcSEcCtD
Nafarelin—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.00859	0.00859	CcSEcCtD
Nafarelin—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.00859	0.00859	CcSEcCtD
Nafarelin—Acne—Dexamethasone—ankylosing spondylitis	0.00853	0.00853	CcSEcCtD
Nafarelin—Acne—Betamethasone—ankylosing spondylitis	0.00853	0.00853	CcSEcCtD
Nafarelin—Herpes simplex—Dexamethasone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Nafarelin—Herpes simplex—Betamethasone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Nafarelin—Acne—Prednisone—ankylosing spondylitis	0.00743	0.00743	CcSEcCtD
Nafarelin—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.00738	0.00738	CcSEcCtD
Nafarelin—Pleural effusion—Methotrexate—ankylosing spondylitis	0.00682	0.00682	CcSEcCtD
Nafarelin—Increased appetite—Prednisolone—ankylosing spondylitis	0.00664	0.00664	CcSEcCtD
Nafarelin—Affect lability—Prednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Nafarelin—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Nafarelin—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Nafarelin—Mood swings—Prednisolone—ankylosing spondylitis	0.00591	0.00591	CcSEcCtD
Nafarelin—Eye pain—Dexamethasone—ankylosing spondylitis	0.00577	0.00577	CcSEcCtD
Nafarelin—Eye pain—Betamethasone—ankylosing spondylitis	0.00577	0.00577	CcSEcCtD
Nafarelin—Dry skin—Prednisolone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Nafarelin—Oliguria—Methotrexate—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Nafarelin—Herpes simplex—Methotrexate—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Nafarelin—Affect lability—Triamcinolone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Nafarelin—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Nafarelin—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00554	0.00554	CcSEcCtD
Nafarelin—Increased appetite—Betamethasone—ankylosing spondylitis	0.00554	0.00554	CcSEcCtD
Nafarelin—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00551	0.00551	CcSEcCtD
Nafarelin—Mood swings—Triamcinolone—ankylosing spondylitis	0.00544	0.00544	CcSEcCtD
Nafarelin—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Nafarelin—Mood swings—Methylprednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Nafarelin—Sweating increased—Prednisolone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Nafarelin—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Nafarelin—Affect lability—Betamethasone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Nafarelin—Affect lability—Dexamethasone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Nafarelin—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Nafarelin—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Nafarelin—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Nafarelin—Cystitis—Methotrexate—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Nafarelin—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.005	0.005	CcSEcCtD
Nafarelin—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Nafarelin—Mood swings—Betamethasone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Nafarelin—Mood swings—Dexamethasone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Nafarelin—Weight increased—Prednisolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Nafarelin—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Nafarelin—Increased appetite—Prednisone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Nafarelin—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00482	0.00482	CcSEcCtD
Nafarelin—Dry skin—Betamethasone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Nafarelin—Dry skin—Dexamethasone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Nafarelin—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Nafarelin—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Nafarelin—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Nafarelin—Weight increased—Triamcinolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Nafarelin—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Nafarelin—Affect lability—Prednisone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Nafarelin—Sweating increased—Betamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Nafarelin—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Nafarelin—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Nafarelin—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Nafarelin—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Nafarelin—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Nafarelin—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Nafarelin—Mood swings—Prednisone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Nafarelin—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00417	0.00417	CcSEcCtD
Nafarelin—Dry skin—Prednisone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Nafarelin—Weight increased—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nafarelin—Weight increased—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nafarelin—Weight decreased—Betamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Nafarelin—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Nafarelin—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Nafarelin—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Nafarelin—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Nafarelin—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Nafarelin—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Nafarelin—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Nafarelin—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Nafarelin—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Nafarelin—Sweating increased—Prednisone—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Nafarelin—Weight increased—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Nafarelin—Depression—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Nafarelin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Nafarelin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Nafarelin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Nafarelin—Vertigo—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Nafarelin—Alopecia—Dexamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Nafarelin—Alopecia—Betamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Nafarelin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Nafarelin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Nafarelin—Oedema—Prednisolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Nafarelin—Shock—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Nafarelin—Convulsion—Triamcinolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Nafarelin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Nafarelin—Myalgia—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Nafarelin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Nafarelin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Nafarelin—Depression—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nafarelin—Oedema—Triamcinolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Nafarelin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Nafarelin—Vertigo—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Nafarelin—Shock—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nafarelin—Alopecia—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Nafarelin—Shock—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Nafarelin—Malnutrition—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Nafarelin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Nafarelin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Nafarelin—Convulsion—Dexamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Nafarelin—Convulsion—Betamethasone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Nafarelin—Myalgia—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Nafarelin—Myalgia—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Nafarelin—Oedema—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Nafarelin—Oedema—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Nafarelin—Insomnia—Triamcinolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Nafarelin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Nafarelin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Nafarelin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Nafarelin—Shock—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nafarelin—Shock—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nafarelin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nafarelin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nafarelin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nafarelin—Vertigo—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Nafarelin—Anorexia—Dexamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Nafarelin—Anorexia—Betamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Nafarelin—Convulsion—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nafarelin—Myalgia—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nafarelin—Insomnia—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nafarelin—Insomnia—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nafarelin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Nafarelin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Nafarelin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Nafarelin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Nafarelin—Oedema—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Nafarelin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Nafarelin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Nafarelin—Shock—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Nafarelin—Anorexia—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nafarelin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Nafarelin—Urticaria—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Nafarelin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Nafarelin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Nafarelin—Insomnia—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Nafarelin—Pruritus—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Nafarelin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nafarelin—Rash—Prednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Nafarelin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Nafarelin—Headache—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Nafarelin—Constipation—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Nafarelin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Nafarelin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Nafarelin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Nafarelin—Asthenia—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Nafarelin—Nausea—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Nafarelin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Nafarelin—Pruritus—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Nafarelin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nafarelin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nafarelin—Rash—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nafarelin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nafarelin—Rash—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nafarelin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Nafarelin—Urticaria—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Nafarelin—Headache—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Nafarelin—Headache—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Nafarelin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Nafarelin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Nafarelin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nafarelin—Dizziness—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nafarelin—Nausea—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Nafarelin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Nafarelin—Vomiting—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nafarelin—Vomiting—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Nafarelin—Rash—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Nafarelin—Rash—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Nafarelin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Nafarelin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Nafarelin—Headache—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Nafarelin—Headache—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Nafarelin—Asthenia—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Nafarelin—Pruritus—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Nafarelin—Nausea—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Nafarelin—Nausea—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Nafarelin—Dizziness—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Nafarelin—Vomiting—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Nafarelin—Rash—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Nafarelin—Headache—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Nafarelin—Nausea—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Nafarelin—Rash—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Nafarelin—Headache—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Nafarelin—Nausea—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
